In insulin-naive T2D, weekly efsitora was noninferior to daily degludec for reducing HbA(1c) at 52 wk. Larios F, Gionfriddo MR, Montori VM. Ann Intern Med 2025;178:JC10.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Larios F, Gionfriddo MR, Montori VM. In insulin-naive T2D, weekly efsitora was noninferior to daily degludec for reducing HbA(1c) at 52 wk. Ann Intern Med 2025;178:JC10.
PMID: 39761579